Portola Pharmaceuticals Gets $70M In Series C
South San Francisco-based Portola Pharmaceuticals has raised $70M in a Series C funding, the firm said Monday. The round included new investors Brookside Capital, AllianceBernstein LP, Teachers' Private Capital, Goldman Sachs, T. Rowe Price, IBTM and CIDC. Prior investors Abingworth, Alta Partners, Advanced Technology Ventures, Frazier Healthcare, MPM Capital, Prospect Ventures and Sutter Hill Ventures also participated. Portola is developing two candidates focused on treatment for actue and chronic cardiovascular and vascular disease.
posted on Monday, May 7, 2007 (Link to more information)
Related companies:
Portola Pharmaceuticals
Related stories:
> Portola Pharmaceuticals Raises $89M
> Portola Pharmaceuticals Lands $60M
> Third Rock Ventures Raises $426M Fund, Sets Up Shop In San Francisco
> Aldea Pharmaceuticals Takes $24M
> Gene Security Network Raises $4M
silicontap.com Home